Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways
Liping You, Tao Wang, Wenxuan Li, Jinghao Zhang, Chao Zheng, Yanxi Zheng, Suyin Li, Zhi Shang, Jiacheng Lin, Fang Wang, Yihan Qian, Zhijia Zhou, Xiaoni Kong, Yueqiu Gao, Xianbing Sun
Topics & Concepts
AMPKLipid metabolismFatty liverPeroxisome proliferator-activated receptorMetabolismMedicinePharmacologyMetabolic pathwayChemistryEndocrinologyBiochemistryInternal medicineDiseaseEnzymeProtein kinase AReceptorLiver Disease Diagnosis and TreatmentMetabolism, Diabetes, and CancerPeroxisome Proliferator-Activated Receptors